Compare Quest Diagnostics Inc (DGX) vs Carparts.Com Inc (PRTS) Price & Performance

Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.

DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.

CarParts.com (PRTS) trades at $5.66, down 3.58% today, with a bearish technical signal despite recent positive developments including Nasdaq compliance and a $25 million credit facility. The company shows improving operational metrics with three consecutive earnings beats, though it remains unprofitable with negative margins and cash flow. Valuation metrics appear attractive with P/S of 0.07 and P/B of 0.77, but fundamental challenges persist.

While analyst sentiment is positive (60% buy ratings) and recent corporate actions provide stability, PRTS faces significant execution risks amid declining revenue and persistent losses. The stock offers speculative appeal for turnaround investors but requires careful monitoring of cash burn and profitability improvements. Near-term catalysts include Q2 2026 earnings results expected at -$0.85 EPS.